In this review, we summarize the up-to-date development of PSMA-targeted nanocarriers as PCa theranostics, including hydrophilic polymers, supramolecular NPs, liposomes, metal NPs, and dendrimers (Figure 1). Here, FOLH1 is linked to posterior cortical atrophy.